Product image of Glipizide Bp Galena (Glipizide) supplied by GNH India

Glipizide Bp Galena

Active Ingredient:
Glipizide
Origin:
EU

Glipizide Bp Galena (Glipizide)

Glipizide Bp Galena is a prescription oral medication that contains the active ingredient glipizide, a sulfonylurea class drug used to manage blood glucose levels in adults with type 2 diabetes mellitus. It is marketed in the European Union and is taken by mouth as directed by a healthcare professional.

Manufacturer / TM Owner

Farmaceutyczna Spoldzielnia Pracy Galena

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glipizide Bp Galena is indicated for the treatment of type 2 diabetes mellitus when diet, exercise, and other non‑pharmacologic measures are insufficient to achieve glycemic control.

  • Improves fasting and post‑prandial blood glucose levels.
  • Used as part of a comprehensive diabetes management plan that includes diet and exercise.
  • May be combined with other antidiabetic agents when monotherapy is inadequate.
  • Helps reduce HbA1c levels in patients with established type 2 diabetes.
  • Prescribed for adults who have not achieved target glucose levels with lifestyle changes alone.

Side Effects

Glipizide Bp Galena can cause a range of side effects, most of which are mild and transient, but some may require medical attention.

Common

  • Low blood sugar (hypoglycemia) symptoms such as shakiness, sweating, or dizziness.
  • Nausea or upset stomach.
  • Headache.
  • Weight gain.
  • Skin rash or itching.

Serious

  • Severe hypoglycemia leading to loss of consciousness.
  • Allergic reactions including swelling of the face, lips, or throat.
  • Liver function abnormalities.
  • Blood disorders such as leukopenia or thrombocytopenia.

Precautions & Warnings

Before starting Glipizide Bp Galena, certain health considerations should be reviewed to ensure safe use.

  • Assess renal and hepatic function, as impairment may affect drug clearance.
  • Monitor blood glucose regularly to detect hypoglycemia early.
  • Use caution in elderly patients who may be more sensitive to low blood sugar.
  • Discuss any history of allergic reactions to sulfonylureas.
  • Inform the prescriber of pregnancy or breastfeeding status, as safety data are limited.
  • Review concomitant use of other glucose‑lowering agents to avoid additive effects.

Avoid Interactions

Glipizide Bp Galena may interact with several medications, altering its efficacy or safety profile.

Avoid

  • Other sulfonylureas or insulin, which can increase the risk of severe hypoglycemia.
  • Strong CYP2C9 inhibitors (e.g., fluconazole, amiodarone) that may raise glipizide levels.
  • Certain diuretics that can affect blood glucose control.

Use with caution

  • Non‑steroidal anti‑inflammatory drugs (NSAIDs) that may mask hypoglycemia symptoms.
  • Beta‑blockers, which can blunt typical hypoglycemia warning signs.
  • Antidepressants such as SSRIs that may influence glucose metabolism.

Frequently Asked Questions

Glipizide stimulates insulin release from pancreatic beta cells by binding to the sulfonylurea receptor subunit of the ATP‑sensitive potassium channel, which helps lower blood glucose levels.

Renal function should be evaluated before prescribing glipizide. Dose adjustments or alternative therapies may be needed for patients with moderate to severe kidney impairment.

Blood glucose should be checked regularly, often daily at first, and then as advised by a healthcare professional to ensure adequate control and to detect hypoglycemia early.

Glipizide can be combined with other oral agents, but the combination may increase the risk of hypoglycemia. The prescribing clinician should adjust doses and monitor closely.

Common signs include shakiness, sweating, rapid heartbeat, dizziness, hunger, and confusion. Severe hypoglycemia may cause loss of consciousness or seizures.

Weight gain is listed as a common side effect of glipizide, likely due to improved glucose utilization and reduced glycosuria.

Patients are often advised to withhold glipizide on the day of surgery or before fasting periods to reduce the risk of hypoglycemia, but they should follow their surgeon’s instructions.

The safety of glipizide in pregnancy has not been established, so it is generally avoided unless the potential benefit justifies the potential risk to the fetus.

Baseline and periodic liver enzyme tests (ALT, AST, bilirubin) are recommended, especially if the patient has a history of liver disease.

Alcohol can potentiate the hypoglycemic effect of glipizide and may also cause delayed hypoglycemia, so moderate consumption is advised and patients should be monitored.

Yes, glipizide is marketed as a generic medication in many regions, including the European Union, under various brand names.

If a dose is missed, the patient should take it as soon as they remember unless it is close to the time of the next scheduled dose. They should not double the dose.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Glipizide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT